Regulatory Radar – Tracking the trends, talent and transformation shaping biotech and medtech

Hayley has worked within Regulatory Affairs recruitment for almost a decade and has built a strong reputation for placing high-quality Regulatory Affairs and QA professionals across the US life sciences sector, from Associate through to Head of level. She specialises in partnering with Phase II/III biotechs (typically <200 employees), working closely with senior stakeholders to shape hiring strategies, define role requirements, and streamline recruitment processes to ensure efficient, high-quality outcomes. 

As someone who specialises in Regulatory Affairs recruitment, I spend my days speaking with regulatory leaders, founders, hiring managers and consultants. My aim isn’t to report every headline, but to highlight the developments shaping regulatory strategy, hiring decisions and business outcomes.

This month, three themes stand out: growing concerns around FDA review capacity, increasing demand for specialist regulatory expertise, and the evolving hiring landscape across East Coast biotech and medtech.

FDA Staffing Concerns and Regulatory Timelines

Over the past month, concerns around FDA staffing levels and review capacity have continued to generate discussion across the biotech and medtech sectors.

While the long-term impact remains uncertain, many industry leaders are asking the same question:

Could reduced agency resources lead to longer review timelines and increased pressure on sponsors?

For companies preparing key submissions, uncertainty creates risk. Delays can affect everything from fundraising timelines and product launches to commercial planning and investor confidence.

As a result, regulatory teams are under increasing pressure to ensure submissions are as robust as possible before reaching the agency. Organisations are looking to minimise avoidable review cycles, strengthen pre-submission strategies and identify potential regulatory challenges earlier in the development process.

For smaller biotech and medtech companies, this challenge is particularly significant. Unlike larger organisations, many don’t have the resources or portfolio diversification to absorb major regulatory delays.

So what does this mean for hiring talent?

One interesting consequence is the growing value of regulatory professionals who can operate strategically rather than purely tactically.

Hiring managers are increasingly seeking individuals who can:

• Develop proactive FDA engagement strategies
• Anticipate regulatory questions before submission
• Influence development decisions earlier in the process
• Reduce reliance on multiple agency review cycles

The ability to navigate uncertainty is becoming just as important as technical regulatory knowledge.

The Growing Demand for Specialist Regulatory Expertise

One trend that continues to emerge is the increasing demand for highly specialised regulatory talent.

Areas generating the strongest demand include:

• FDA Regulatory Strategy
• Global Regulatory Affairs
• AI and Digital Health Regulation
• Software as a Medical Device (SaMD)
• MDR and IVDR Expertise
• Regulatory Affairs and Quality Leadership

Many organisations are looking for professionals who can combine strategic thinking with hands-on execution. Individuals who can lead regulatory initiatives while remaining close enough to the detail to drive progress internally and this is creating challenges for both industry and consulting organisations.

For hiring managers, candidate availability remains limited in several of these niche areas. For consultancies, increasing client demand means attracting and retaining experienced regulatory specialists has become a priority in its own right.

The result is a highly competitive market for professionals who possess both technical expertise and strong stakeholder management skills.

Growth is substantial on the East Coast, USA

Across the East Coast biotech ecosystem, businesses continue to balance growth ambitions with financial discipline.

While funding conditions remain more selective than in previous years, many organisations are continuing to invest in programmes that are closest to key value-creating milestones.

This is influencing hiring decisions. Rather than broad team expansion, many companies are focusing on targeted hires that can directly support regulatory, clinical or commercial objectives.

From a Regulatory Affairs perspective, this often means prioritising individuals who can:

• Navigate complex submissions
• Manage external consultants and partners
• Build scalable regulatory processes
• Support global market expansion
• Communicate effectively with executive leadership teams

The businesses continuing to invest in regulatory capability are often doing so because they recognise the direct connection between regulatory execution and wider business performance.

Observations and implications for hiring in regulatory affairs

One of the most common conversations I’ve had recently centres around the challenge of finding regulatory professionals who can operate strategically.

Most organisations can identify candidates with technical expertise, but finding individuals who can also influence senior stakeholders, align regulatory plans with commercial objectives and navigate organisational complexity is much harder.

The strongest candidates in today’s market are often those who combine technical credibility with business awareness.

For hiring managers, this raises an important question:

Are you hiring someone to manage regulatory activity, or are you hiring someone to influence business outcomes through regulatory strategy?

If there is one takeaway from this month’s market activity, it is that Regulatory Affairs continues to gain influence across biotech and medtech organisations.

Whether it’s uncertainty around FDA review capacity, increasing complexity in digital health regulation, or pressure to hit critical development milestones, regulatory expertise is becoming a genuine competitive advantage. The organisations that are best positioned for success are those that view Regulatory Affairs as more than a compliance function. They’re bringing regulatory leaders into strategic discussions earlier, investing in specialist expertise and recognising the role that strong regulatory capability plays in driving business outcomes.

As the market continues to evolve, the ability to attract and retain the right regulatory talent will remain a key differentiator.

Hayley Shayestehroo

Senior Consultant